Sonographic Predictors and Outcomes of Second-Dose Misoprostol in Early Pregnancy Loss

超声预测因素及米索前列醇二剂治疗早期妊娠丢失的结局

阅读:1

Abstract

BACKGROUND: Misoprostol is a preferred medical agent for managing early pregnancy loss. However, the optimal protocol, particularly repeat dosing, remains a topic of debate. OBJECTIVE: To evaluate the effectiveness of a second dose of misoprostol in women with incomplete uterine evacuation after the first dose, and to examine sonographic findings and demographic data to identify factors associated with successful treatment. METHODS: Retrospective descriptive study of electronic medical records from a tertiary university-affiliated hospital. We identified women who had early pregnancy loss and received a second dose of misoprostol vaginally after an incomplete response to the first dose. RESULTS: A second dose of misoprostol achieved a 49% success rate for uterine evacuation without surgical intervention. Demographic and obstetric characteristics were similar in both the intervention and non-intervention groups; 44% of delayed miscarriages and 49% of anembryonic pregnancies with an intact sac persisted after the second dose (p<0.001). Delayed miscarriage and anembryonic pregnancy after the first dose significantly increased the odds of surgical intervention (delayed miscarriage: odds ratio (OR) 4.138, 95% confidence interval (CI) 1.513-11.317; anembryonic pregnancy: OR 2.921, 95% CI 1.349-6.326). CONCLUSION: A second dose of misoprostol offers effective care. Sonographic results after the first dose help forecast the need for surgical intervention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。